Patent · US Active

2,4,6-trisubstituted s-triazine compound, preparation method therefor, and use thereof

US11390591B2 · kind B2 · utility

0Cited by

1References

12Claims

0Family size

Assignee

Aluda Pharmaceuticals, Inc. · US

Inventors

Qizheng Yao · 安丰镇, CN
Jianping Wu · Shoreview, US
Ruihuan Chen · Meekrap-oord, CN
Lei Zhang · Beijing, CN
Shining Yao · 安丰镇, CN
Lian Mo · Palo Alto, US
Qingqing Zhang · Shanghai, CN

Key dates

Filing date	Feb 26, 2020
Grant date	Jul 19, 2022
Priority date	—
Expiry date	Feb 26, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D403/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides a 2,4,6-trisubstituted s-triazine compound represented by general formula (I) or pharmaceutically acceptable salts, prodrugs or solvates thereof, a preparation method therefor, and use of these compounds in preparing drugs for preventing or treating diseases associated with protein kinase and vimentin dysregulation, and cell vacuolization, and in particular, drugs for treating or preventing cancer growth and metastasis, tissue fibrosis and atherosclerosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.